1. Bal Pharma
stock logo

Bal Pharma Share Price

BALPHARMA

₹102.90+₹1.20 (1.18%) Past Year
₹100.30₹105.85
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹175 Cr

Open

₹105.85

Close

₹101.70

Circuit range

₹122.00 - ₹81.40

Day range

₹100.30 - ₹105.85

Year range

₹69.60 - ₹132.45

Volume

11,809

Avg. traded

₹102.54

Revenue (12m)

₹327 Cr

Bal PharmaBal Pharma Limited is a fully integrated pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It is specialized in bulk actives, prescription drugs, generics and pharma intermediates. Its focused therapeutic areas are anti-diabetes, anti-histamine, anti-inflammatory, acne treatment, gastroenterology, cardiology, and dermatology. It offers a range of APIs, which includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment. Its finished formulation products cover dosage forms, such as tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments. The Company offers a range of natural medicine, which includes ANARSHA, ASHWAMED, AYURFINE, AYURFINE FORTE, AYURSULIN, IMMUWIN, LIPIVED, MENOLEAP CAPSULES, MENOLEAP SYRUP, PROLIFE, and BALPRO SYRUP.

Read more

Bal Pharma Key indicators

arrow

52 week high

₹132.45

52 week low

₹69.60

P/E ratio

46.41

P/B ratio

2.54

ROE

6.8%

ROCE

10.25%

Dividend yield

0.97%

Debt/Equity ratio

1.32

EPS

3.9

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

9.34%

Net profit margin

2.02%

ROE

6.8%

ROA

1.92%

ROCE

10.25%

Learn more

Bal Pharma Shareholder returns

arrow

1 day

+1.18%

1 week

+2.90%

1 month

-3.74%

3 months

-9.38%

1 year

+39.43%

3 years

+56.98%

5 years

+45.03%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Bal Pharma Share Price history

arrow
DayOpenCloseDay’s change
Wed, Apr 10 2024
₹105.85
₹102.90
-2.87%
Tue, Apr 9 2024
₹104.20
₹101.70
-2.46%
Mon, Apr 8 2024
₹102.10
₹103.85
+1.69%
Fri, Apr 5 2024
₹104.40
₹103.25
-1.11%
Thu, Apr 4 2024
₹99.20
₹102.50
+3.22%
Wed, Apr 3 2024
₹102.40
₹100.00
-2.40%
Tue, Apr 2 2024
₹96.80
₹99.85
+3.05%
Mon, Apr 1 2024
₹92.40
₹96.80
+4.55%

Shareholding info

arrow

Promoters (51.23%)

Mutual Funds (0%)

Retail and other (48.64%)

Foreign institutions-FII (0.13%)

Other domestic institutions (0%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹1/share

    Ex date 18 Sep 2023

    expand tab
  • Dividend • ₹1/share

    Ex date 13 Sep 2022

    expand tab

Learn more

Frequently asked questions